期刊
JOURNAL OF CELLULAR BIOCHEMISTRY
卷 117, 期 2, 页码 289-299出版社
WILEY
DOI: 10.1002/jcb.25291
关键词
PAGET'S DISEASE; BONE DISEASE; BISPHOSPHONATES
资金
- Arthritis Research UK
- MRC [G0701625] Funding Source: UKRI
- Medical Research Council [G0701625] Funding Source: researchfish
- Versus Arthritis [19799] Funding Source: researchfish
Paget's disease of bone (PDB) is a common skeletal disorder characterized by increased and disorganized bone remodeling affecting one or more skeletal sites. Although some patients are asymptomatic others develop complications such as bone pain, deformity, nerve compression syndromes, and fragility fractures. Genetic factors play an important role in the pathogenesis of PDB and there is strong evidence that susceptibility is determined by variants within or close to genes that regulate osteoclast function. Environmental factors also play a key role but the nature of the environmental triggers is less clear. Bisphosphonates are a highly effective treatment for the elevations in bone turnover that are characteristic of PDB but it is unclear at present if they alter the natural history of the disease. Here, we review the epidemiology, clinical, cellular, and molecular abnormalities in PDB as well as environmental and genetic triggers, and current available treatment options. (C) 2015 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据